Intervention Protocol

Prucalopride for the treatment of chronic constipation

  1. Ali Rezaie1,
  2. Edwin J Cheng2,
  3. Humberto B Jijon2,
  4. Sushil Kumar3,
  5. Martin Storr2,4,*

Editorial Group: Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group

Published Online: 15 FEB 2012

Assessed as up-to-date: 1 OCT 2011

DOI: 10.1002/14651858.CD009636


How to Cite

Rezaie A, Cheng EJ, Jijon HB, Kumar S, Storr M. Prucalopride for the treatment of chronic constipation (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD009636. DOI: 10.1002/14651858.CD009636.

Author Information

  1. 1

    University of Calgary, Faculty of Medicine, Calgary, AB, Canada

  2. 2

    University of Calgary, Department of Medicine, Calgary, Alberta, Canada

  3. 3

    All India Institute of Medical Sciences, New Delhi, Delhi, India

  4. 4

    University of Munich, Department of Medicine, Munich, Germany

*Martin Storr, gidoc@gmx.com. mstorr@ucalgary.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 15 FEB 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary objective is to assess the efficacy and safety of prucalopride for the treatment of chronic constipation.